• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北卡纳塔克邦女性人群中非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)的发病率:一项横断面研究。

Incidence of Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) in the Female Population of North Karnataka: A Cross-Sectional Study.

作者信息

Desai Geeta S, Hajare Santosh, Ghorpade Sandesha

机构信息

Department of Gastroenterology and Hepatology, Karnatak Lingayat Education Society's (KLES) Dr. Prabhakar Kore Hospital and Medical Research Centre, KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, IND.

出版信息

Cureus. 2024 Aug 6;16(8):e66257. doi: 10.7759/cureus.66257. eCollection 2024 Aug.

DOI:10.7759/cureus.66257
PMID:39238753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11375481/
Abstract

BACKGROUND

India is currently facing an epidemic of type 2 diabetes mellitus (T2DM) and obesity which are high-risk factors for the development of non-alcoholic fatty liver disease (NAFLD). A non-invasive tool, the vibration-controlled transient elastography (VCTE; FibroScan, Echosens, Paris, France) is used to diagnose NAFLD.

AIM

To identify the prevalence, spectrum, and metabolic determinants of NAFLD in Indian adult women using liver function tests (LFT) and non-invasive FibroScan (liver stiffness measure, i.e., LSM score) of the liver through a cross-sectional population-based study in the city of Belagavi.

METHODS

The subjects were screened for the presence of liver disease with a detailed history, anthropometric measurements, LFTs, blood sugars, and FibroScan of the liver to assess liver steatosis and liver fibrosis.

RESULTS

The study included 2448 women with 860 (35.13%) having NAFLD (controlled attenuation parameter {CAP}≥275 dB/m) as detected by FibroScan. Nearly, 58.8% of the participants with T2DM had NAFLD. Participants with NAFLD had higher BMI and waist circumference. When univariate logistic regression was applied, those with T2DM were 14.5 times (95% CI, 4.55, 6.52) likely to have CAP≥275 dB/m. Similarly, those with higher BMI>23 mg/m were 1.34 (95% CI, 1.68, 2.37) times more likely to have CAP ≥275 dB/m. The risk of NAFLD increases by ~1% for every one-year increase in age.

CONCLUSION

NAFLD in women is the most common non‑communicable disease in India; a prevalence of 35.13% was observed in the present study in women. Higher BMI, presence of metabolic risk factors, and incremental age were associated with a high risk of developing NAFLD in women.

摘要

背景

印度目前正面临2型糖尿病(T2DM)和肥胖症的流行,这两种疾病是非酒精性脂肪性肝病(NAFLD)发展的高危因素。一种非侵入性工具,即振动控制瞬时弹性成像(VCTE;FibroScan,Echosens,法国巴黎),用于诊断NAFLD。

目的

通过在贝拉尔加维市进行的一项基于人群的横断面研究,使用肝功能测试(LFT)和肝脏的非侵入性FibroScan(肝脏硬度测量,即LSM评分)来确定印度成年女性中NAFLD的患病率、范围和代谢决定因素。

方法

通过详细的病史、人体测量、LFT、血糖和肝脏FibroScan对受试者进行肝病筛查,以评估肝脏脂肪变性和肝纤维化。

结果

该研究纳入了2448名女性,其中860名(35.13%)经FibroScan检测患有NAFLD(控制衰减参数{CAP}≥275 dB/m)。近58.8%的T2DM参与者患有NAFLD。患有NAFLD的参与者BMI和腰围更高。应用单因素逻辑回归分析时,患有T2DM的人CAP≥275 dB/m的可能性是正常人的14.5倍(95%CI,4.55,6.52)。同样,BMI>23 mg/m的人CAP≥275 dB/m的可能性高1.34倍(95%CI,1.68,2.37)。年龄每增加一岁,患NAFLD的风险增加约1%。

结论

女性NAFLD是印度最常见的非传染性疾病;在本研究中,女性的患病率为35.13%。较高的BMI、代谢危险因素的存在以及年龄的增加与女性患NAFLD的高风险相关。

相似文献

1
Incidence of Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) in the Female Population of North Karnataka: A Cross-Sectional Study.北卡纳塔克邦女性人群中非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)的发病率:一项横断面研究。
Cureus. 2024 Aug 6;16(8):e66257. doi: 10.7759/cureus.66257. eCollection 2024 Aug.
2
Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.瞬时弹性成像用于评估 2 型糖尿病患者非酒精性脂肪性肝病的患病率:来自 CORDIAL 队列研究的证据。
Saudi J Gastroenterol. 2022 Nov-Dec;28(6):426-433. doi: 10.4103/sjg.sjg_73_22.
3
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.对肥胖症手术候选者的肝脂肪变性分级及非酒精性脂肪性肝炎检测中瞬时弹性成像、磁共振成像和血清评分的前瞻性比较
JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec.
4
Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.应用瞬时弹性成像技术筛查 2 型糖尿病患者的非酒精性脂肪性肝病。
J Gastroenterol Hepatol. 2019 Aug;34(8):1396-1403. doi: 10.1111/jgh.14577. Epub 2019 Jan 21.
5
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会(INASL)关于非酒精性脂肪性肝病(NAFLD)命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
6
Genetic Variants in nicotinamide-N-methyltransferase (NNMT) gene are related to the stage of non-alcoholic fatty liver disease diagnosed by controlled attenuation parameter (CAP)-fibroscan.烟酰胺 - N - 甲基转移酶(NNMT)基因中的遗传变异与通过受控衰减参数(CAP)- 瞬时弹性成像诊断的非酒精性脂肪性肝病分期相关。
J Gastrointestin Liver Dis. 2018 Sep;27(3):265-272. doi: 10.15403/jgld.2014.1121.273.wsh.
7
Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter.使用具有受控衰减参数的振动控制瞬时弹性成像技术同时筛查罗马尼亚2型糖尿病患者的肝脂肪变性和肝纤维化
Diagnostics (Basel). 2022 Jul 20;12(7):1753. doi: 10.3390/diagnostics12071753.
8
Prevalence, Metabolic Profile, and Associated Risk Factors of Non-alcoholic Fatty Liver Disease in an Adult Population of India.印度成年人群中非酒精性脂肪性肝病的患病率、代谢特征及相关危险因素
Cureus. 2023 Jan 19;15(1):e33977. doi: 10.7759/cureus.33977. eCollection 2023 Jan.
9
Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.印度北部人群中非酒精性脂肪性肝病的流行率、谱及决定因素的城乡差异。
PLoS One. 2022 Feb 10;17(2):e0263768. doi: 10.1371/journal.pone.0263768. eCollection 2022.
10
Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience.在单中心真实世界经验中,使用振动控制瞬时弹性成像和受控衰减参数对大量2型糖尿病患者进行肝纤维化和脂肪变性筛查
J Clin Med. 2020 Apr 6;9(4):1032. doi: 10.3390/jcm9041032.

本文引用的文献

1
Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis.印度非酒精性脂肪性肝病危险因素的评估:一项系统评价和荟萃分析。
J Educ Health Promot. 2024 Jan 22;12:435. doi: 10.4103/jehp.jehp_208_23. eCollection 2023.
2
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.非酒精性脂肪性肝病与 2 型糖尿病患者心血管疾病及全因死亡的相关性:全国范围内基于人群的研究。
BMJ. 2024 Feb 13;384:e076388. doi: 10.1136/bmj-2023-076388.
3
Prevalence of Non-Alcoholic Fatty Liver Disease in Urban Adult Population in a Tertiary Care Center, Chennai.
钦奈一家三级医疗中心城市成年人群中非酒精性脂肪性肝病的患病率
Indian J Community Med. 2023 Jul-Aug;48(4):601-604. doi: 10.4103/ijcm.ijcm_437_22. Epub 2023 Jul 14.
4
Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysis.南亚地区成年人非酒精性脂肪性肝病的患病率及相关因素:一项荟萃分析。
Lancet Reg Health Southeast Asia. 2023 May 24;15:100220. doi: 10.1016/j.lansea.2023.100220. eCollection 2023 Aug.
5
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.非酒精性脂肪性肝病患者的 2 型糖尿病、肝功能失代偿和肝细胞癌:个体参与者水平数据荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Sep;8(9):829-836. doi: 10.1016/S2468-1253(23)00157-7. Epub 2023 Jul 4.
6
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会(INASL)关于非酒精性脂肪性肝病(NAFLD)命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
7
The Link between NAFLD and Metabolic Syndrome.非酒精性脂肪性肝病与代谢综合征之间的联系。
Diagnostics (Basel). 2023 Feb 7;13(4):614. doi: 10.3390/diagnostics13040614.
8
Prevalence, Metabolic Profile, and Associated Risk Factors of Non-alcoholic Fatty Liver Disease in an Adult Population of India.印度成年人群中非酒精性脂肪性肝病的患病率、代谢特征及相关危险因素
Cureus. 2023 Jan 19;15(1):e33977. doi: 10.7759/cureus.33977. eCollection 2023 Jan.
9
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
10
Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.印度非酒精性脂肪性肝病的患病率:一项系统评价与荟萃分析。
J Clin Exp Hepatol. 2022 May-Jun;12(3):818-829. doi: 10.1016/j.jceh.2021.11.010. Epub 2021 Nov 25.